Clinical Trials Sponsored by Mereo BioPharma
Total 1402 results
-
Mereo BioPharmaCompletedHypogonadotropic HypogonadismUnited States, Italy, Spain, United Kingdom
-
Mereo BioPharmaCompletedInteractionUnited States
-
Mereo BioPharmaCompleted
-
Mereo BioPharmaCompletedPulmonary Disease, Chronic ObstructiveUnited States, Bulgaria, Czechia, Germany, Hungary, Italy, Latvia, Poland, Romania, Russian Federation
-
Mereo BioPharmaCompleted
-
Mereo BioPharmaNovartisCompleted
-
Mereo BioPharmaNovartisCompletedChronic Obstructive Pulmonary DiseaseRussian Federation, Bulgaria, Romania
-
Mereo BioPharmaNovartisTerminatedPelvic Pain Associated With Refractory EndometriosisUnited States, Puerto Rico
-
Mereo BioPharmaNovartisTerminatedAcute Kidney InjuryTaiwan, United States, Israel
-
Mereo BioPharmaNovartisTerminatedObese Hypogonadotropic HypogonadismUnited States, Canada
-
Mereo BioPharmaSyneos HealthCompletedEmphysema | Alpha 1-Antitrypsin Deficiency | COPDUnited Kingdom, Belgium, United States, Denmark, Canada, Sweden, Poland, Spain
-
Ultragenyx Pharmaceutical IncMereo BioPharmaWithdrawnOsteogenesis ImperfectaUnited States
-
OncoMed Pharmaceuticals, Inc.TerminatedPrimary Peritoneal CarcinomaUnited States
-
OncoMed Pharmaceuticals, Inc.CompletedRelapsed or Refractory Solid TumorsUnited States
-
OncoMed Pharmaceuticals, Inc.TerminatedMetastatic Colorectal CancerUnited States
-
Ultragenyx Pharmaceutical IncMereo BioPharmaCompletedOsteogenesis Imperfecta Type III | Osteogenesis Imperfecta Type IV | Osteogenesis Imperfecta, Type IUnited States, Canada, Denmark, France, United Kingdom
-
OncoMed Pharmaceuticals, Inc.CompletedSolid TumorsUnited States
-
OncoMed Pharmaceuticals, Inc.CompletedPancreatic Cancer | Stage IV Pancreatic CancerUnited States
-
OncoMed Pharmaceuticals, Inc.Completed
-
OncoMed Pharmaceuticals, Inc.CompletedMetastatic Breast CancerUnited States
-
OncoMed Pharmaceuticals, Inc.Completed
-
OncoMed Pharmaceuticals, Inc.Completed
-
OncoMed Pharmaceuticals, Inc.CompletedAdvanced Solid Tumor MalignanciesUnited States
-
OncoMed Pharmaceuticals, Inc.CompletedMetastatic Colorectal CancerUnited States
-
Ultragenyx Pharmaceutical IncMereo BioPharmaActive, not recruitingOsteogenesis ImperfectaUnited States, Turkey, Germany, United Kingdom, Italy, Portugal, Canada, Australia, Argentina, France, Netherlands, Poland
-
Mereo BioPharmaICON Clinical ResearchCompletedAdvanced Solid Tumor | Metastatic Solid Tumor | Solid Tumor, AdultUnited States, United Kingdom
-
Ultragenyx Pharmaceutical IncMereo BioPharmaTerminatedOsteogenesis ImperfectaUnited States
-
OncoMed Pharmaceuticals, Inc.Completed
-
OncoMed Pharmaceuticals, Inc.CompletedSolid TumorsUnited States
-
OncoMed Pharmaceuticals, Inc.TerminatedStage IV Small Cell Lung CancerUnited States
-
OncoMed Pharmaceuticals, Inc.CompletedRelapsed or Refractory Lymphoid MalignanciesUnited States
-
OncoMed Pharmaceuticals, Inc.CompletedPancreatic Cancer | Stage IV Pancreatic CancerUnited States
-
OncoMed Pharmaceuticals, Inc.CompletedCancer Ovaries | Cancer Peritoneal | Cancer, Fallopian TubeUnited States
-
OncoMed Pharmaceuticals, Inc.CompletedRefractory Solid Tumors | Advanced Relapsed TumorsUnited States
-
OncoMed Pharmaceuticals, Inc.CompletedLiver Cancer | Hepatocellular CancerUnited States
-
OncoMed Pharmaceuticals, Inc.TerminatedMetastatic Cancer | Locally Advanced Malignant NeoplasmUnited States
-
OncoMed Pharmaceuticals, Inc.TerminatedMetastatic Cancer | Locally Advanced CancerUnited States
-
M.D. Anderson Cancer CenterMereo BioPharmaCompleted
-
Ultragenyx Pharmaceutical IncNovartis; Mereo BioPharmaWithdrawnChronic-kidney Disease Stage 5D on Stable Hemodialysis
-
Ultragenyx Pharmaceutical IncNovartis; Mereo BioPharmaCompleted
-
Ultragenyx Pharmaceutical IncNovartis; Mereo BioPharmaCompletedOsteoporosis | OsteopeniaUnited States
-
OncoMed Pharmaceuticals, Inc.BayerCompleted
-
University of Alabama at BirminghamMereo BioPharmaCompleted
-
OncoMed Pharmaceuticals, Inc.Celgene CorporationCompletedPancreatic CancerUnited States, Canada, United Kingdom, Spain, Australia, Belgium
-
OncoMed Pharmaceuticals, Inc.Celgene CorporationCompletedNonsquamous Nonsmall Cell Neoplasm of LungSpain, United States, Australia, Italy, Belgium
-
OncoMed Pharmaceuticals, Inc.Celgene CorporationCompletedLocally Advanced or Metastatic Solid TumorsUnited States, United Kingdom
-
OncoMed Pharmaceuticals, Inc.Novotech (Australia) Pty LimitedCompletedPancreatic CancerAustralia, New Zealand, Spain
-
OncoMed Pharmaceuticals, Inc.Novotech (Australia) Pty LimitedCompletedNon Small Cell Lung CancerAustralia, New Zealand, Spain
-
OncoMed Pharmaceuticals, Inc.Novotech (Australia) Pty LimitedCompletedColorectal CancerAustralia, New Zealand
-
University of Alabama at BirminghamNational Institutes of Health (NIH); Mereo BioPharmaCompletedEmphysema or COPD | Alpha-1 Antitrypsin Deficiency (AATD) | Pi*ZZ, Pi*SZ, Pi*Null, Another Rare Phenotype/Genotype Known to be Associated With Either Low or Functionally Impaired AAT Including F or I MutationsUnited States